Rural Health
Resources by Topic: Healthcare business and finance
COVID-19 Affected Rural and Urban Hospital Uncompensated Care
Offers data comparing the impact of COVID-19 on uncompensated hospital care on rural and urban facilities using Medicare Cost Report data for acute care hospitals. Discusses uncompensated care trends over time and analyzes operating expenses.
Author(s): Emmaline Keesee
Date: 03/2024
Type: Document
Sponsoring organization: The Cecil G. Sheps Center for Health Services Research
view details
Offers data comparing the impact of COVID-19 on uncompensated hospital care on rural and urban facilities using Medicare Cost Report data for acute care hospitals. Discusses uncompensated care trends over time and analyzes operating expenses.
Author(s): Emmaline Keesee
Date: 03/2024
Type: Document
Sponsoring organization: The Cecil G. Sheps Center for Health Services Research
view details
The 340B Drug Pricing Program: A Small Part of the Prescription Drug Market, Delivering Large Benefits to Patients and Communities
Analyzes impacts of the 340B Drug Pricing Program on access, hospital finance, drug companies, and public expenditures. Discusses how the 340B program is shaped by legislation, policy, finance, prescribing patterns, and market influences. Highlights rural and underserved communities throughout.
Date: 03/2024
Type: Document
Sponsoring organization: American Hospital Association
view details
Analyzes impacts of the 340B Drug Pricing Program on access, hospital finance, drug companies, and public expenditures. Discusses how the 340B program is shaped by legislation, policy, finance, prescribing patterns, and market influences. Highlights rural and underserved communities throughout.
Date: 03/2024
Type: Document
Sponsoring organization: American Hospital Association
view details
Hearing on Enhancing Access to Care at Home in Rural and Underserved Communities
Recording of a March 12, 2024, House Committee on Ways and Means hearing regarding opportunities and challenges to enhance access to care in patients' homes and modernizing care in rural and underserved communities, with a focus on telehealth and health information technology. Features testimony from two rural patients and representatives from Intermountain Health; Cadence, a company with expertise in chronic care management through remote physiologic monitoring; and Harvard Medical School and Beth Israel Deaconess Medical Center.
Additional links: Ateev Mehrotra, Harvard Medical School and Beth Israel Deaconess Medical Center - Testimony, Bell Maddux, Home Dialysis Patient - Testimony, Chris Altchek, Cadence - Testimony, Nathan Starr, Intermountain Health - Testimony, Roy Underhill, Hospital at Home Patient - Testimony
Date: 03/2024
Type: Video/Multimedia
Sponsoring organization: House Ways and Means Committee
view details
Recording of a March 12, 2024, House Committee on Ways and Means hearing regarding opportunities and challenges to enhance access to care in patients' homes and modernizing care in rural and underserved communities, with a focus on telehealth and health information technology. Features testimony from two rural patients and representatives from Intermountain Health; Cadence, a company with expertise in chronic care management through remote physiologic monitoring; and Harvard Medical School and Beth Israel Deaconess Medical Center.
Additional links: Ateev Mehrotra, Harvard Medical School and Beth Israel Deaconess Medical Center - Testimony, Bell Maddux, Home Dialysis Patient - Testimony, Chris Altchek, Cadence - Testimony, Nathan Starr, Intermountain Health - Testimony, Roy Underhill, Hospital at Home Patient - Testimony
Date: 03/2024
Type: Video/Multimedia
Sponsoring organization: House Ways and Means Committee
view details
Generic Drug Utilization and Spending Among Medicare Part D Enrollees in 2022
Issue brief on prescriptions for generic drugs filled by Medicare Part D enrollees using 2022 Part D prescription drug event (PDE) data. Covers commonly used prescription drugs, costs, and conditions treated, and includes data breakdowns by plan type, race and ethnicity, and level of rurality throughout. Discusses formulary design to improve access by promoting affordability and reducing confusion among enrollees.
Author(s): Yevgeniy Feyman, Bisma Sayed, Kenneth Finegold, et al.
Date: 03/2024
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Issue brief on prescriptions for generic drugs filled by Medicare Part D enrollees using 2022 Part D prescription drug event (PDE) data. Covers commonly used prescription drugs, costs, and conditions treated, and includes data breakdowns by plan type, race and ethnicity, and level of rurality throughout. Discusses formulary design to improve access by promoting affordability and reducing confusion among enrollees.
Author(s): Yevgeniy Feyman, Bisma Sayed, Kenneth Finegold, et al.
Date: 03/2024
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
2024 National Impact Assessment of the Centers for Medicare & Medicaid Services (CMS) Quality Measures Report
Evaluates the quality measures used across 26 Centers for Medicare & Medicaid Services (CMS) quality reporting programs. Explores whether quality measure scores during the COVID-19 public health emergency (2020-2021) differed from expected trends. Analyzes how different population groups, including urban and rural residents, performed at a national level in order to inform future quality measure development and advance health equity. Provides statistics concerning participation and performance within Medicare quality reporting programs, including statistics specific to rural populations and facilities.
Additional links: Appendices ZIP File
Date: 03/2024
Type: Document
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
Evaluates the quality measures used across 26 Centers for Medicare & Medicaid Services (CMS) quality reporting programs. Explores whether quality measure scores during the COVID-19 public health emergency (2020-2021) differed from expected trends. Analyzes how different population groups, including urban and rural residents, performed at a national level in order to inform future quality measure development and advance health equity. Provides statistics concerning participation and performance within Medicare quality reporting programs, including statistics specific to rural populations and facilities.
Additional links: Appendices ZIP File
Date: 03/2024
Type: Document
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
Rural–Urban Differences in Out-of-Network Treatment Initiation and Engagement Rates for Substance Use Disorders
Explores disparities in access to substance use disorder treatments among privately insured individuals in rural and urban areas between 2016-2018. Compares rates of initial and ongoing treatment for alcohol use disorder, opioid use disorder, and other drug use disorders overall and from out-of-network providers for urban and rural patients.
Author(s): Eli Raver, Sheldon M. Retchin, Yiting Li, Andrew D. Carlo, Wendy Y. Xu
Citation: Health Services Research
Date: 03/2024
Type: Document
view details
Explores disparities in access to substance use disorder treatments among privately insured individuals in rural and urban areas between 2016-2018. Compares rates of initial and ongoing treatment for alcohol use disorder, opioid use disorder, and other drug use disorders overall and from out-of-network providers for urban and rural patients.
Author(s): Eli Raver, Sheldon M. Retchin, Yiting Li, Andrew D. Carlo, Wendy Y. Xu
Citation: Health Services Research
Date: 03/2024
Type: Document
view details
Merit-based Incentive Payment System (MIPS) 2024 Small Practice Eligibility and Participation Frequently Asked Questions
Provides answers to frequently asked questions regarding small practice participation and eligibility for the Merit-based Incentive Payment System (MIPS) for the 2024 performance year. Covers individual and group eligibility, the low-volume threshold, changes to group composition during the performance year, and more.
Date: 03/2024
Type: Document
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
Provides answers to frequently asked questions regarding small practice participation and eligibility for the Merit-based Incentive Payment System (MIPS) for the 2024 performance year. Covers individual and group eligibility, the low-volume threshold, changes to group composition during the performance year, and more.
Date: 03/2024
Type: Document
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
Nonmetropolitan Premiums, Issuer Participation, and Enrollment in Health Insurance Marketplaces in 2022
Policy brief describing differences in unsubsidized and net-of-subsidy premiums in 2022 between nonmetropolitan and metropolitan counties in Health Insurance Marketplace plan design and availability. Features statistics with breakdowns by metropolitan, micropolitan, and noncore areas.
Author(s): Abigail Barker, Ayushi Shrivastava, Eliot Jost, Timothy McBride, Keith Mueller
Date: 03/2024
Type: Document
Sponsoring organization: RUPRI Center for Rural Health Policy Analysis
view details
Policy brief describing differences in unsubsidized and net-of-subsidy premiums in 2022 between nonmetropolitan and metropolitan counties in Health Insurance Marketplace plan design and availability. Features statistics with breakdowns by metropolitan, micropolitan, and noncore areas.
Author(s): Abigail Barker, Ayushi Shrivastava, Eliot Jost, Timothy McBride, Keith Mueller
Date: 03/2024
Type: Document
Sponsoring organization: RUPRI Center for Rural Health Policy Analysis
view details
Breast Cancer Screening among Medicare Advantage Enrollees with Dementia
Compares rates of mammogram screening among screening-eligible women with Alzheimer's disease and related dementias (ADRD) using 2012-2019 Medicare Current Beneficiary Survey data. Compares screening rates of Medicare Advantage and fee-for-service Medicare enrollees, with data breakdowns by race and ethnicity, rural versus urban status, and more. Identifies potential risks related to over-screening.
Author(s): Eli Raver, Wendy Y. Xu, Jean Jung, Sunmin Lee
Citation: BMC Health Services Research, 24, 283
Date: 03/2024
Type: Document
view details
Compares rates of mammogram screening among screening-eligible women with Alzheimer's disease and related dementias (ADRD) using 2012-2019 Medicare Current Beneficiary Survey data. Compares screening rates of Medicare Advantage and fee-for-service Medicare enrollees, with data breakdowns by race and ethnicity, rural versus urban status, and more. Identifies potential risks related to over-screening.
Author(s): Eli Raver, Wendy Y. Xu, Jean Jung, Sunmin Lee
Citation: BMC Health Services Research, 24, 283
Date: 03/2024
Type: Document
view details
Use of In-Network Insurance Benefits Is Critical for Improving Retention in Telehealth-Based Buprenorphine Treatment
Evaluated 3,842 patients in an opioid use disorder (OUD) telehealth company to identify associations in insurance status and treatment program retention. Patient characteristic data includes breakdown by urbanicity, age, gender, race and ethnicity, buprenorphine status, and more.
Author(s): Arthur Robin Williams, Christopher Row, Lexie Minarik, et al.
Citation: Health Affairs Scholar, 2(3)
Date: 03/2024
Type: Document
view details
Evaluated 3,842 patients in an opioid use disorder (OUD) telehealth company to identify associations in insurance status and treatment program retention. Patient characteristic data includes breakdown by urbanicity, age, gender, race and ethnicity, buprenorphine status, and more.
Author(s): Arthur Robin Williams, Christopher Row, Lexie Minarik, et al.
Citation: Health Affairs Scholar, 2(3)
Date: 03/2024
Type: Document
view details